Literature DB >> 18362039

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

Ruth Broering1, Jun Wu, Zhongji Meng, Philip Hilgard, Mengji Lu, Martin Trippler, Agnes Szczeponek, Guido Gerken, Joerg F Schlaak.   

Abstract

BACKGROUND/AIMS: The aim of this study was to further elucidate the role of the IFN and the Toll-like receptor (TLR) system in the control of HCV replication by non-parenchymal liver cells (NPC).
METHODS: Murine HCV replicon bearing MH1 cells were incubated with supernatants from TLR1-9-stimulated murine NPC (Kupffer cells (KC), liver sinusoidal endothelial cells (LSEC)) and bone marrow-derived myeloid dendritic cells (mDC). HCV replication and expression of IFN-stimulated genes (ISGs) as well as TLR1-9 mRNA were determined by real-time rtPCR.
RESULTS: IFNs (-alpha, -beta, -gamma) and TLR3 ligands only (despite the expression of TLR1-7 and TLR9 mRNA) achieved direct suppression of HCV replication by about 80-90% or 60%, respectively. Supernatants from TLR3- and 4-stimulated NPC only, however, led to potent suppression of HCV replication through IFN-beta and induction of ISGs. By contrast, mDCs could be stimulated by TLR2, -3, -4, -7 and -9 to produce antiviral cytokines.
CONCLUSIONS: TLR3- and TLR4-stimulated NPC are able to regulate HCV replication through production of IFN-beta. This can also, at least partly explain the high level of ISG expression in HCV infected livers. These novel findings are of particular relevance for the control of HCV replication by the innate immune system of the liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362039     DOI: 10.1016/j.jhep.2008.01.028

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  45 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

2.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

Review 3.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

Review 4.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

Review 5.  Organ system view of the hepatic innate immunity in HCV infection.

Authors:  Bo-Ram Bang; Sandra Elmasry; Takeshi Saito
Journal:  J Med Virol       Date:  2016-05-13       Impact factor: 2.327

6.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

7.  Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.

Authors:  Christian Bleau; Aveline Filliol; Michel Samson; Lucie Lamontagne
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

Review 8.  Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.

Authors:  Jessica Brownell; Stephen J Polyak
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

9.  TLRs in Hepatic Cellular Crosstalk.

Authors:  Amelie E Bigorgne; Ian Nicholas Crispe
Journal:  Gastroenterol Res Pract       Date:  2010-08-30       Impact factor: 2.260

10.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.

Authors:  Jinsheng Guo; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.